Skip to main content
FinSpry Logo
FinSpry
EDIT logo
EDIT
(NASDAQ)
Editas Medicine, Inc.
$3.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Editas Medicine (EDIT) Stock Price & Financial Analysis

Editas Medicine Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.97 - $3.18
52-Week High$4.54
52-Week Low$1.66
Open$3.14
Volume2.06M
Average Volume (3M)1.95M
Market Cap293.64M
Shares Outstanding97.88M
Price to Sales (P/S)7.18
Price to Book (P/B)63.06
EV/EBITDA-2.26
Revenue (TTM)38.69M
Net Income (TTM)-108.95M
Free Cash Flow (TTM)-141.09M
EPS (TTM)$-1.21
Profit Margin-281.59%
Operating Margin-230.09%
Return on Equity (ROE)-2471.73%
Debt to Equity16.33
50-Day MA$2.87
200-Day MA$2.59
52-Week Change-6.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Editas Medicine

What is the current stock price for EDIT?

As of the latest trading session, EDIT stock trades at $3.00. The 52-week range is $1.66–$4.54, with a day range of $2.97–$3.18.

What is the P/E ratio for EDIT?

The P/E ratio (Price-to-Earnings) for EDIT is shown in the Key Statistics section. This valuation metric helps compare Editas Medicine, Inc. to industry peers.

Does EDIT pay dividends?

Editas Medicine does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EDIT?

Based on 1 analyst, the consensus for EDIT is Buy.

What is the market cap of EDIT?

Editas Medicine's market capitalization is $293.6M, classifying it as a micro-cap company. Editas Medicine operates in the Healthcare sector within the Biotechnology industry.